ProvenCare

Home > Other > ProvenCare > Page 23
ProvenCare Page 23

by Glenn D Steele


  Steele, Glenn D., xiii, xv, 20, 34, 42, 47, 70, 79–80, 113, 191

  Steele, Glenn D., Jr., 4, 49–50, 79-80, 92-94

  Steele, Glenn D., Sr., 49–50

  Strategic prioritization process, 31–32

  Strategic vision, for care reengineering, 34–36

  Structural design elements, 55–68

  Success:

  in operationalizing and scaling, 54–60

  from tailoring expectations to strengths and structural/cultural aspects, 34

  Surgery:

  at-home equipment boxes for patients following, 201

  calls to patients before, 200

  Tecfidera, 169

  Technology:

  communication, 65–66

  IT enabling reengineering, 161–117

  IT in support of EHRs, 160, 161

  in ProvenHealth Navigator, 128–129

  (See also Electronic health records [EHR])

  Thomas, Cassandra, 228

  TIME magazine, 11

  Transition to home care, 201–202

  Transitions of care, 156

  Transparency, in reporting quality metrics, 194–195

  Type 2 diabetes care, 57–58

  best practice goals for, 10–11

  outcome measures, 147

  performance measures for, 112–117

  ProvenCare reengineering for, 108–109

  UCLA Health, 193

  Ulcerative colitis, 169

  Ultraviolet light (UV) treatment, 181–183

  Uniforms, 197–198

  University of California San Francisco, 18

  U.S. Department of Health and Human Services, 209

  U.S. News & World Report, 12

  Utilization measures, 162

  UV (ultraviolet light) treatment, 181–183

  Value:

  linking mission to, 35

  payment for, 220–221

  unlocking, 53

  Value creation:

  direct benefit from, xvi

  redistribution of profits from, 30

  Value reengineering, 4–10

  culture of innovation for, 5–6

  with electronic health records, 6–7

  enabling (see Enabling change)

  expanding to ProvenCare Chronic, 106–107

  high-probability early wins in, 22

  initiating (see Initiating change)

  and patient population, 7–8

  permitting and recovering from failure in, 8–9

  in ProvenCare Biologics, 167

  sweet spot in, 9–10

  Variation in care/performance:

  with biological medications, 166

  inventorying breadths and depths of, 86

  justified, 87

  in physicians’ practices, 155

  unjustified, 81–82

  Venditti, Angelo, 196

  Vertical integration, xiii, xiv

  Vertically integrated payer/provider model, 26–27

  criticisms of, 26

  legal challenge to, 43

  moving culture toward, 27–29

  (See also ProvenCare)

  Virginia Mason Health System, 27

  Warranties, 83, 89, 202

  Web portal, 203

  Wellness, focus on, 17

  Whiteboards, 199–200

  Wilensky, Gail, 45

  xG Health Solutions, xvii, 74–76, 216

  rationale for creating, 75

  scaling and generalizing, 37–38

  in scaling outside of Geisinger, 71–72

  ABOUT THE AUTHORS

  Glenn D. Steele Jr., MD, PhD, serves as chairman of xG Health Solutions, an independently operated venture Geisinger launched to help healthcare organizations create value and improve quality, leveraging Geisinger intellectual property and expertise on issues such as population-health data analytics, care management, and health IT. He is the former president and chief executive officer of Geisinger Health System (2001–2015). Dr. Steele previously served as the dean of the Biological Sciences Division and the Pritzker School of Medicine and vice president for medical affairs at the University of Chicago, as well as the Richard T. Crane Professor in the Department of Surgery. Prior to that, he was the William V. McDermott Professor of Surgery at Harvard Medical School, president and chief executive officer of Deaconess Professional Practice Group, and chairman of the Department of Surgery at New England Deaconess Hospital. Dr. Steele is past chairman of the American Board of Surgery.

  His investigations have focused on the cell biology of gastrointestinal cancer and precancer and most recently on innovations in healthcare delivery and financing. A prolific writer, he is the author or coauthor of nearly 500 scientific and professional articles.

  Dr. Steele received his bachelor’s degree in history and literature from Harvard University and his medical degree from New York University School of Medicine. He completed his internship and residency in surgery at the University of Colorado, where he was also a fellow of the American Cancer Society. He earned his PhD in microbiology at Lund University in Sweden.

  A member of the National Academy of Medicine, Dr. Steele serves on the Roundtable on Value and Science-Driven Healthcare, the Committee on the Governance and Financing of Graduate Medical Education, and the Vital Directions for Health and Health Care Steering Committee, and previously served on the Committee on Reviewing Evidence to Identify Highly Effective Clinical Services (HECS). A fellow of the American College of Surgeons, Dr. Steele is a member of the American Surgical Association, the American Society of Clinical Oncology, and past president of the Society of Surgical Oncology.

  Dr. Steele serves on the following boards and national committees: Health Transformation Alliance (vice chair), City of Hope board of directors, Ingenious Med board of directors, PTC Therapeutics board of directors, Stratus Video board of directors, Synaptive Medical board of directors, Wellcare Health Plans Inc. board of directors, Healthcare Innovation Program (HIP) external advisory board (Emory University), and the Peterson Center on Healthcare advisory board. Dr. Steele formerly served on the following boards: Agency for Integrated Care (AIC) Singapore, Bucknell University board of trustees, Cepheid board of directors, Harvard Medical Faculty physicians board at Beth Israel Deaconess Medical Center, Premier, Inc. board (chairman 2011–2013), Temple University School of Medicine board of visitors, Weis Markets, Inc., Congressional Budget Office panel of health advisers, Commonwealth Fund’s Commission on a High Performance Health System, and American Hospital Association (AHA) board of trustees.

  Dr. Steele is the recipient of several awards, NYU School of Medicine’s Solomon A. Berson Medical Alumni Achievement Award in Health Science, Medicine and the Arts (2016); AHA’s Justin Ford Kimball Innovators Award (2015); NCHL Gail L. Warden Healthcare Leadership Award (2014); HFMA Board of Directors’ Award (2011); AHA Health Research & Education Trust Award (2010); AHA’s Grassroots Champion Award (2007); and CEO IT Achievement Award (2006). He has been named consecutive times to the following lists: Modern Healthcare’s 50 Most Powerful Physician Executives in Healthcare, Modern Healthcare’s 100 Most Powerful People in Healthcare, and Becker’s Hospital Review’s 100 Nonprofit Hospital Health System CEOs to Know.

  David T. Feinberg, MD, MBA, is president and chief executive officer of Geisinger, one of the nation’s largest health services organizations known for reinventing medical care. Geisinger is an integrated healthcare organization consisting of 13 hospital campuses, two research centers, a school of medicine, over 30,000 employees, 1,600 employed physicians, 420 residents and fellows, and a 583,000-member health plan, all serving and caring for more than 3 million residents in Pennsylvania and New Jersey.

  A longtime champion of the patient experience, Dr. Feinberg has caught the industry’s attention by introducing Geisinger’s latest evolution of its renowned ProvenCare portfolio: ProvenExperience, which allows patients to request a refund based on the outcome of their patient experience.

  Prior to joining Geisinger, Dr. Feinbe
rg served as CEO of UCLA’s hospitals and associate vice chancellor of UCLA Health Sciences, as well as president of UCLA Health System.

  Triple-board certified by the American Board of Psychiatry and Neurology in child, adolescent, and addiction psychiatry, Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley, and graduated with distinction from the University of Health Sciences/Chicago Medical School. He earned a master of business administration from Pepperdine University.

  Recognized among the 100 Most Influential People in Healthcare as well as in the top 3 of the 50 Most Influential Physician Executives and Leaders by Modern Healthcare, Dr. Feinberg’s numerous awards and recognitions include Alpha Omega Alpha Medical Honor Society; Medical Center CEO of the Year Healthcare Leadership Award; Leadership, Vision, and Commitment Honoree by the National Health Foundation; Distinguished Fellow of the American Psychiatric Association; and the Cancro Academic Leadership Award from the American Academy of Child and Adolescent Psychiatry. Dr. Feinberg is a well-known national speaker, especially on the subject of patient experience, and has published numerous articles.

  ABOUT GEISINGER

  Geisinger is a leading integrated health services organization widely recognized for its unwavering commitment to caring and innovation, including the development of pioneering care delivery models, such as ProvenCare, ProvenExperience, and ProvenHealth Navigator.

  Everything Geisinger does is about caring—for its patients, its members, the Geisinger family of physicians and employees, and its communities. As an organization, Geisinger values:

  • Kindness: We strive to treat everyone as we would hope to be treated ourselves.

  • Excellence: We treasure colleagues who humbly strive for excellence.

  • Learning: We share our knowledge with the best and brightest to better prepare the caregivers of tomorrow.

  • Innovation: We constantly seek new and better ways to care for our patients, our members, our communities and the nation.

  In addition to fulfilling its patient care mission, Geisinger has a long-standing commitment to medical education, research, and community service. The MyCode Community Health Initiative at Geisinger includes one of the world’s largest biobanks designed to store blood and other samples for DNA analysis research use by Geisinger and Geisinger collaborators.

  Geisinger serves more than three million residents throughout central, south-central, and northeast Pennsylvania, and in New Jersey at AtlantiCare, a Malcolm Baldrige National Quality Award recipient. The physician-led organization includes approximately 30,000 employees, 1,600 employed physicians, 13 hospital campuses, two research centers, a 580,000+ member health plan, and Geisinger Commonwealth School of Medicine, all of which leverage an estimated $12.7 positive annual impact on the Pennsylvania and New Jersey economies.

  Geisinger has repeatedly garnered national accolades for integration, service, quality, and value. For more information, visit www.geisinger.org or connect on Facebook, Instagram, Linke dIn, and Twitter.

  ABOUT XG HEALTH SOLUTIONS

  With roots in Geisinger—one of America’s most innovative and successful integrated delivery systems—xG Health Solutions® enables healthcare organizations to optimize clinical and value-based performance through proven care redesign and management, actionable analytics, and industry-leading content.

  Its team of clinically-led experts and its solutions accelerate and sustain value transformation through:

  • Care Redesign and Workflow Optimization: improve outpatient, inpatient, and transition of care through care designs and workflows that have been successful at Geisinger and other high-functioning organizations

  • Care Management: organizational structures, policies, procedures, clinical protocols, workflows, training via xG Learn™, and supervision, so providers can implement effective care management programs

  • Actionable Data Analytics: data analytic expertise and clinical and financial management experience to help organizations identify and prioritize opportunities to improve quality of care and reduce cost

  • xG Intelligent Care Management™: adult and pediatric care management assessments that automatically suggest patient-specific care plans for Medicare, Medicaid, and commercial patients based on evidence-based guidelines and social determinants of health.

  xG Health Solutions works with leading healthcare organizations from Maine to Singapore. Its clients and partners include:

  • Providers: hospitals, health systems, and physician groups that are currently taking or planning to take financial risk

  • Health Insurers: who work collaboratively with providers to achieve success in value-based payment arrangements

  • Employers: who seek to work with health providers and insurers in a fundamentally different way to achieve better outcomes and value

  • EHR and HIT Vendors: who incorporate its intellectual property into their products

  xG Health Solutions is the leader in optimizing care delivery and care management, driving the behavioral change necessary to achieve and sustain value transformation reliably. For more information, please visit www.xghealth.com.

 

 

 


‹ Prev